ImmunityBio Inc. is a clinical-stage biopharmaceutical company focused on developing immunotherapies and vaccines to combat various diseases, including cancer and infectious diseases. They utilize advanced technologies and platforms to create personalized treatments and enhance the body's immune response to fight against these conditions. 

In terms of technical analysis, the stock of ImmunityBio Inc. has recently completed a long-term breakout. A breakout occurs when the stock price surpasses a significant resistance level, indicating a potential shift in market sentiment and the start of a new upward trend. 

This long-term breakout suggests that investors have gained confidence in the stock's prospects, leading to increased buying pressure and a subsequent rally. Traders and investors may view this breakout as a signal to consider long positions or further monitor the stock's performance for potential trading opportunities.